FDA Inspection 1249624 — Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. — FEI 3003744377

The FDA completed an inspection of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on August 23, 2024 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Taizhou (China)